SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-006503
Filing Date
2022-03-10
Accepted
2022-03-10 16:05:43
Documents
13
Period of Report
2022-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40526
2 ex99-1.htm EX-99.1 12228
  Complete submission text file 0001493152-22-006503.txt   231711

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cytr-20220308.xsd EX-101.SCH 3024
4 XBRL LABEL FILE cytr-20220308_lab.xml EX-101.LAB 35156
5 XBRL PRESENTATION FILE cytr-20220308_pre.xml EX-101.PRE 23023
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3725
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 22729064
SIC: 2836 Biological Products, (No Diagnostic Substances)